Loan Agreements in the Biotechnology Industry

1,114 Contracts & Agreements

Browse by Company

89bio, Inc. (5 contracts)
AbbVie Inc. (7)
ACCELERON PHARMA INC (1)
Achaogen, Inc. (7)
ACHIEVE LIFE SCIENCES, INC. (1)
Adamas Pharmaceuticals Inc (3)
Adhera Therapeutics, Inc. (2)
ADiTx Therapeutics, Inc. (4)
ADMA BIOLOGICS, INC. (8)
AGENUS INC (1)
AgeX Therapeutics, Inc. (3)
Akebia Therapeutics, Inc. (3)
Akero Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (2)
Aldeyra Therapeutics, Inc. (9)
Alexion Pharmaceuticals (2)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (2)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (2)
Altimmune, Inc. (1)
ALX ONCOLOGY HOLDINGS INC (3)
AMARIN CORP PLC (1)
Amgen Inc. (2)
ANAPTYSBIO INC (3)
ANAVEX LIFE SCIENCES CORP. (5)
Apellis Pharmaceuticals, Inc. (1)
APPLIED GENETIC TECHNOLOGIES CORP (2)
Aptinyx Inc. (1)
AquaBounty Technologies, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
ARCA biopharma, Inc. (7)
Arcturus Therapeutics Holdings Inc. (4)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (6)
Arsanis, Inc. (8)
Athenex, Inc. (1)
aTYR PHARMA INC (5)
AVEO PHARMACEUTICALS INC (9)
Avid Bioservices, Inc. (3)
Avidity Biosciences, Inc. (1)
AVROBIO, Inc. (2)
Axcella Health Inc. (5)
Axovant Sciences Ltd. (4)
AZIYO BIOLOGICS, INC. (6)
BAKKEN RESOURCES INC (1)
BeiGene, Ltd. (3)
BELLICUM PHARMACEUTICALS, INC (7)
BICYCLE THERAPEUTICS Ltd (3)
BIOCEPT INC (6)
BioLife4D Corp (2)
BIOMARIN PHARMACEUTICAL INC (5)
BioRestorative Therapies, Inc. (2)
BIOVIE INC. (2)
BioXcel Therapeutics, Inc. (1)
Blueprint Medicines Corp (2)
BridgeBio Pharma, Inc. (8)
CALADRIUS BIOSCIENCES, INC. (5)
CANCER GENETICS, INC (8)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (12)
Capstone Therapeutics Corp. (4)
CareDx, Inc. (4)
CASI Pharmaceuticals, Inc. (2)
CASTLE BIOSCIENCES INC (7)
Castle Creek Biosciences, Inc. (1)
CATALYST BIOSCIENCES, INC. (3)
Celcuity Inc. (2)
Celldex Therapeutics, Inc. (4)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (4)
Celsion CORP (6)
Century Therapeutics, Inc. (2)
Chardan Healthcare Acquisition Corp. (1)
Chelsea Worldwide Inc. (7)
ChemoCentryx, Inc. (8)
CHIMERIX INC (1)
Cidara Therapeutics, Inc. (7)
CLEVELAND BIOLABS INC (5)
Coherus BioSciences, Inc. (3)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (3)
CONSTELLATION PHARMACEUTICALS INC (2)
Corbus Pharmaceuticals Holdings, Inc. (2)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (1)
CTD HOLDINGS INC (19)
CTI BIOPHARMA CORP (8)
Cue Biopharma, Inc. (1)
Cyclacel Pharmaceuticals, Inc. (1)
Cytokinetics, Incorporated (8)
CytomX Therapeutics, Inc. (3)
CYTORI THERAPEUTICS, INC. (20)
CYTRX CORP (3)
DelMar Pharmaceuticals, Inc. (1)
Dermavant Sciences Ltd (1)
Dermira, Inc. (2)
Dicerna Pharmaceuticals Inc (2)
DYADIC INTERNATIONAL INC (1)
DYNAVAX TECHNOLOGIES CORP (5)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (5)
Eidos Therapeutics, Inc. (2)
Eiger BioPharmaceuticals, Inc. (9)
Elevation Oncology, Inc. (1)
Emerald Bioscience, Inc. (1)
Emergent BioSolutions Inc. (10)
Enochian Biosciences Inc (1)
Epizyme, Inc. (2)
Equillium, Inc. (4)
Esperion Therapeutics, Inc. (4)
Evelo Biosciences, Inc. (9)
EXACT SCIENCES CORP (4)
Exelixis (6)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (5)
FENNEC PHARMACEUTICALS INC. (4)
Finch Therapeutics Group, Inc. (1)
Foghorn Therapeutics Inc. (2)
Fortress Biotech, Inc. (1)
Frequency Therapeutics, Inc. (1)
Fusion Pharmaceuticals Inc. (3)
G1 Therapeutics, Inc. (5)
GALECTIN THERAPEUTICS INC (1)
Gamida Cell Ltd. (1)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (1)
GENOCEA BIOSCIENCES, INC. (8)
GERON CORP (4)
Gilead Sciences (1)
Global Blood Therapeutics, Inc. (1)
Gritstone Oncology, Inc. (1)
GTX INC (1)
GX Acquisition Corp. (3)
HALOZYME THERAPEUTICS INC (8)
HCW Biologics Inc. (1)
HEAT BIOLOGICS, INC. (10)
HilleVax, Inc. (2)
HISTOGENICS CORP (1)
HUMANIGEN, INC (18)
IMMUCELL CORP (7)
IMMUNE PHARMACEUTICALS INC (6)
Immune Therapeutics, Inc. (2)
IMPEL NEUROPHARMA INC (5)
INFINITY PHARMACEUTICALS, INC. (2)
Inhibikase Therapeutics, Inc. (4)
Inhibrx, Inc. (9)
Inmune Bio, Inc. (1)
Inozyme Pharma, Inc. (1)
INSMED Inc (6)
Instil Bio, Inc. (2)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (6)
Isoray, Inc. (3)
KalVista Pharmaceuticals, Inc. (5)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (3)
Kura Oncology, Inc. (6)
LEXICON PHARMACEUTICALS, INC. (10)
Ligand Pharmaceuticals Incorporated (13)
Locust Walk Acquisition Corp. (4)
LogicBio Therapeutics, Inc. (4)
MADRIGAL PHARMACEUTICALS, INC. (14)
MATEON THERAPEUTICS INC (3)
MEDICINOVA INC (1)
Medovex Corp. (2)
MERRIMACK PHARMACEUTICALS INC (8)
Mersana Therapeutics, Inc. (9)
Metacrine, Inc. (2)
Millendo Therapeutics, Inc. (1)
MiMedx Group, Inc. (1)
Minerva Neurosciences, Inc. (5)
MIRAGEN THERAPEUTICS, INC. (3)
Molecular Templates, Inc. (4)
MUSTANG BIO, INC. (6)
Myovant Sciences Ltd. (2)
NAVIDEA BIOPHARMACEUTICALS, INC. (14)
NEUROBIOLOGICAL TECHNOLOGIES INC (2)
NEWLINK GENETICS CORP (1)
NORTHWEST BIOTHERAPEUTICS INC (20)
NTN BUZZTIME INC (10)
Olema Pharmaceuticals, Inc. (1)
Olivia Ventures, Inc. (4)
Omega Therapeutics, Inc. (3)
OncoCyte Corp (3)
Oncorus, Inc. (1)
Ophthotech Corp. (1)
Opko Health, Inc. (3)
ORAGENICS INC (4)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (17)
PALATIN TECHNOLOGIES INC (1)
PhaseBio Pharmaceuticals Inc (3)
PIERIS PHARMACEUTICALS, INC. (3)
POLARITYTE, INC. (1)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (6)
PRECISION BIOSCIENCES INC (7)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
PREMIER BIOMEDICAL INC (1)
Progenics Pharmaceuticals, Inc. (2)
Prometheus Biosciences, Inc. (1)
Propanc Biopharma, Inc. (1)
PROTEOSTASIS THERAPEUTICS, INC. (4)
PUMA BIOTECHNOLOGY, INC. (8)
Radius Health, Inc. (8)
Regulus Therapeutics Inc. (14)
RenovaCare, Inc. (9)
Replimune Group, Inc. (3)
Rezolute, Inc. (1)
RIGEL PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (3)
Sarepta Therapeutics, Inc. (1)
Savara Inc (13)
Scholar Rock Holding Corp (4)
SELECTA BIOSCIENCES INC (6)
SELLAS Life Sciences Group, Inc. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (3)
Sierra Oncology, Inc. (2)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (1)
SOLENO THERAPEUTICS INC (1)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (5)
Sorrento Therapeutics, Inc. (19)
Spectrum Pharmaceuticals, Inc. (1)
SPHERIX INC (1)
Spring Bank Pharmaceuticals, Inc. (3)
SPRUCE BIOSCIENCES, INC. (3)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (11)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (6)
Syndax Pharmaceuticals Inc (8)
Syros Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (9)
Taysha Gene Therapies, Inc. (1)
TG THERAPEUTICS, INC. (3)
Therapeutics Acquisition Corp. (1)
Tocagen Inc (4)
Tracon Pharmaceuticals, Inc. (8)
TREVENA INC (6)
Trovagene, Inc. (5)
TScan Therapeutics, Inc. (1)
Twist Bioscience Corp (1)
U.S. Stem Cell, Inc. (15)
uniQure N.V. (6)
United Therapeutics Corp (1)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (6)
UroGen Pharma Ltd. (1)
Vaxart, Inc. (2)
VBI Vaccines Inc (4)
Vera Therapeutics, Inc. (2)
VERACYTE, INC. (3)
Verastem, Inc. (6)
Vericel Corp (6)
Viking Therapeutics, Inc. (4)
vTv Therapeutics Inc. (5)
Werewolf Therapeutics, Inc. (3)
WINDTREE THERAPEUTICS INC (20)
Xenon Pharmaceuticals Inc. (3)
Xilio Therapeutics, Inc. (3)
XOMA Corp (13)
ZAFGEN, INC. (1)
ZIOPHARM ONCOLOGY INC (2)

Recent Contracts

Fifth Amendment to Loan and Security Agreement, dated September 22, 2023 (Omega Therapeutics, Inc., Filed With SEC on September 22, 2023)
Loan and Security Agreement, dated September 5, 2023, by and between the Company and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (Olema Pharmaceuticals, Inc., Filed With SEC on September 5, 2023)
Form of Business Loan and Security Agreement dated August 23, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on August 28, 2023)
Third Amendment to Loan Agreement, dated as of June 30, 2023, by and among the Company, Biopharma Credit plc, B (Akebia Therapeutics, Inc., Filed With SEC on August 28, 2023)
Loan Agreement, dated as of August 21, 2023, among Celularity Inc. and the lenders thereto (GX Acquisition Corp., Filed With SEC on August 25, 2023)
First Amendment to Loan and Security Agreement, dated June 16, 2023, by and between the Company and Hercules Capital, Inc (HilleVax, Inc., Filed With SEC on August 14, 2023)
Third Amendment to Loan and Guaranty Agreement, dated July 5, 2023, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative, each... (VBI Vaccines Inc, Filed With SEC on August 14, 2023)
Tenth Amendment to Loan and Security Agreement (CYTORI THERAPEUTICS, INC., Filed With SEC on August 14, 2023)
Consent and Fifth Amendment to Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February 28,... (SUTRO BIOPHARMA, INC., Filed With SEC on August 10, 2023)
Amendment to Loan Agreement, dated June 29, 2023, by and among the Company, UroGen Pharma, Inc., as the borrower, and certain direct and indirect subsidiaries of the Company party... (UroGen Pharma Ltd., Filed With SEC on August 10, 2023)
First Amendment to Loan and Security Agreement by and between Candel Therapeutics, Inc. and Silicon Valley Bank, dated June 14, 2023 (Candel Therapeutics, Inc., Filed With SEC on August 10, 2023)
Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement, dated March 30, 2023, by and among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc.,... (Sorrento Therapeutics, Inc., Filed With SEC on August 10, 2023)
Second Amendment to Loan and Security Agreement, dated as of May 31, 2023 (ALX ONCOLOGY HOLDINGS INC, Filed With SEC on August 10, 2023)
Third Amendment to Loan and Security Agreement, dated April 18, 2023, by and among the Registrant, Scholar Rock, Inc., Oxford Finance LLC and Silicon Valley Bank, a division of... (Scholar Rock Holding Corp, Filed With SEC on August 9, 2023)
Consent and First Amendment to Loan and Security Agreement, by and among the Registrant and Oxford Finance LLC, dated July 19, 2023 (Poseida Therapeutics, Inc., Filed With SEC on August 8, 2023)
Amendment to Loan and Security Agreement, dated June 19, 2023, by and between the Registrant and Oxford Finance, LLC (Regulus Therapeutics Inc., Filed With SEC on August 8, 2023)
Amendment No. 1 to Third Amended and Restated Loan and Security Agreement, dated as of May 12, 2023, by and among uniQure biopharma, B.V., uniQure, Inc., uniQure IP B.V., uniQure... (uniQure N.V., Filed With SEC on August 1, 2023)
Economic Recovery Loan Program Loan Agreement, by and between ImmuCell Corporation and the Finance Authority of Maine dated July 17, 2023 (IMMUCELL CORP, Filed With SEC on July 21, 2023)
Economic Recovery/SSBCI Program Loan Promissory Note for $1,000,000 executed by ImmuCell Corporation in favor of the Finance Authority of Maine dated July 17, 2023 (IMMUCELL CORP, Filed With SEC on July 21, 2023)
Loan Agreement, by and between ImmuCell Corporation and Gorham Savings Bank dated July 17, 2023 (IMMUCELL CORP, Filed With SEC on July 21, 2023)
July Loan Agreement, dated July 5, 2023 (Propanc Biopharma, Inc., Filed With SEC on July 12, 2023)
Debtor-in-Possession Term Loan Facility Summary of Terms and Conditions, dated as of July 5, 2023, between Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc. and Scilex... (Sorrento Therapeutics, Inc., Filed With SEC on July 10, 2023)
Waiver and Amendment to Venture Loan and Security Agreement and Eleventh Extension of Standstill Agreement, dated as of July 7, 2023, by and among Evelo Biosciences, Inc., Horizon... (Evelo Biosciences, Inc., Filed With SEC on July 10, 2023)
Form of Business Loan and Security Agreement dated July 3, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on July 7, 2023)
LOAN AND SECURITY AGREEMENT (COMPASS Pathways plc, Filed With SEC on July 5, 2023)
Second Amendment to Supplement to Loan and Security Agreement, dated June 27, 2023, by and among Avenue Venture Opportunities Fund, L.P., Clene Inc., and Clene Nanomedicine, Inc (Chelsea Worldwide Inc., Filed With SEC on June 30, 2023)
Third Amendment to Loan and Security Agreement, dated June 23, 2023, with Oxford Finance, LLC (LEXICON PHARMACEUTICALS, INC., Filed With SEC on June 28, 2023)
Form of Amended and Restated Secured Loan Agreement, dated as of June 20, 2023, by and between Celularity Inc. and the lender party thereto (GX Acquisition Corp., Filed With SEC on June 21, 2023)
Waiver and Consent to Term Loan Agreement with CRG Servicing LLC, dated May 19, 2023 (T2 Biosystems, Inc., Filed With SEC on May 22, 2023)
Secured Loan Agreement, dated as of May 16, 2023, among Celularity Inc. and the lender party thereto (GX Acquisition Corp., Filed With SEC on May 16, 2023)
Consent and Third Amendment to Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February 28,... (SUTRO BIOPHARMA, INC., Filed With SEC on May 15, 2023)
Consent and Second Amendment to the Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February... (SUTRO BIOPHARMA, INC., Filed With SEC on May 15, 2023)
Consent and Fourth Amendment to Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February 28,... (SUTRO BIOPHARMA, INC., Filed With SEC on May 15, 2023)
Amended and Restated Loan and Security Agreement, dated as of May 5, 2023, by and between Xilio Development, Inc. and Pacific Western Bank (Xilio Therapeutics, Inc., Filed With SEC on May 9, 2023)
Fourth Amendment to Loan and Security Agreement, dated March 23, 2023, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bridge Bank, N.A., and... (Mersana Therapeutics, Inc., Filed With SEC on May 9, 2023)
Second Amendment and Waiver to Loan Agreement dated as of February 6, 2023, among Coherus BioSciences, Inc., the Collateral Agent and the Lenders party thereto (Coherus BioSciences, Inc., Filed With SEC on May 8, 2023)
First Amendment to Amended and Restated Loan and Security Agreement, dated March 31, 2023, by and among TG Therapeutics, Inc., TG Biologics, Inc. and Hercules Capital, Inc (TG THERAPEUTICS, INC., Filed With SEC on May 8, 2023)
Loan Agreement, made and entered into as of May 1, 2023, by and between Dominari Holdings Inc. and Matthew B. McCullough (SPHERIX INC, Filed With SEC on May 5, 2023)
Second Amendment to Loan and Security Agreement, date May 1, 2023, with Oxford Finance, LLC (LEXICON PHARMACEUTICALS, INC., Filed With SEC on May 2, 2023)
Form of Business Loan and Security Agreement, dated April 24, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on April 25, 2023)